Clinical trials recruiting for Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Abemaciclib | 1 |
| Capecitabine | 1 |
| Docetaxel | 1 |
| Elacestrant | 1 |
| Fulvestrant | 1 |
| Goserelin | 1 |
| INX-315 | 1 |
| Letrozole | 1 |
| NKT3964 | 1 |
| Pertuzumab Injection | 1 |
| Tamoxifen | 1 |
| Trastuzumab emtansine | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 3 |
| Florida | 2 |
| Georgia | 2 |
| Texas | 2 |
| Arkansas | 1 |
| California | 1 |
| Colorado | 1 |
| Indiana | 1 |
| Kansas | 1 |
| Michigan | 1 |
| New Jersey | 1 |
| New York | 1 |
Top cities
Self-screener
Recruiting trials
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
- Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
Related conditions
Trials recruiting for Human Epidermal Growth Factor 2 Negative Carcinoma of Breast often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Human Epidermal Growth Factor 2 Negative Carcinoma of Breast trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.